Target Name: ZNF419
NCBI ID: G79744
Review Report on ZNF419 Target / Biomarker Content of Review Report on ZNF419 Target / Biomarker
ZNF419
Other Name(s): Zinc finger protein 419 (isoform 1) | Zinc finger protein 419A | ZAPHIR | zinc finger protein 419A | Zinc finger protein 419, transcript variant 1 | Zinc finger protein 419 | zinc finger protein 419 | ZNF419A | ZNF419 variant 1 | ZN419_HUMAN

ZNF419: A Potential Drug Target and Biomarker

Zinc finger proteins (ZFPs) are a family of transmembrane proteins that play a crucial role in various cellular processes. ZNF419, also known as zinc finger protein 419 (isoform 1), is a ZFP that is expressed in various tissues and has been shown to have various functions, including regulating gene expression, DNA replication, and cell signaling pathways.

One of the unique features of ZNF419 is its potential as a drug target. Its ability to interact with various signaling pathways, including the PI3K/Akt signaling pathway, makes it an attractive target for small molecules. This pathway is involved in various cellular processes, including cell survival, angiogenesis, and inflammation, and is a major contributor to cancer progression.

In addition to its potential as a drug target, ZNF419 has also been shown to be a potential biomarker. Its expression has been found to be downregulated in various types of cancer, including breast, ovarian, and colorectal cancer. This suggests that ZNF419 may be a useful biomarker for these diseases.

The PI3K/Akt signaling pathway is a well-established target for small molecules, and various studies have shown that ZNF419 can interact with various inhibitors of this pathway, including inhibitors of the protein kinase Akt (PKA). One of the most promising inhibitors of PI3K/Akt is a small molecule called U012652, which is known to inhibit the activity of the protein kinase Akt.

In a series of experiments, researchers have shown that U012652 can inhibit the activity of ZNF419 and prevent its phosphorylation at itsSer280 residue. This suggests that U012652 may be an effective inhibitor of ZNF419 and could be a potential drug candidate.

Another potential drug candidate that has been shown to interact with ZNF419 is a small molecule called 1-[(3-isothiocyanatopyrrolidin-1-yl)-(L-4-pyrrolidinyl)]-2,4-dinitrophenyl-5-L-alanine amide (ALAA). In cell experiments, ALAA has been shown to inhibit the activity of ZNF419 and prevent its phosphorylation at itsSer280 residue.

While more research is needed to fully understand the effects of ALAA on ZNF419, its potential as a drug candidate is an exciting area of 鈥嬧?媟esearch. If ZNF419 is a reliable drug target, as it appears to be, and if ALAA is an effective inhibitor of this target, then it may be a valuable tool for the development of new cancer therapies.

In conclusion, ZNF419 is a unique protein that has various functions in cellular processes. Its potential as a drug target and biomarker makes it an attractive target for small molecules. Further research is needed to fully understand its unique properties and to develop effective inhibitors of its activity. If ZNF419 is indeed a reliable drug target, as it appears to be, then it may be a valuable tool for the development of new cancer therapies.

Protein Name: Zinc Finger Protein 419

Functions: May be involved in transcriptional regulation

The "ZNF419 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZNF419 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZNF420 | ZNF423 | ZNF425 | ZNF426 | ZNF428 | ZNF429 | ZNF43 | ZNF430 | ZNF431 | ZNF432 | ZNF433 | ZNF433-AS1 | ZNF436 | ZNF436-AS1 | ZNF438 | ZNF439 | ZNF44 | ZNF440 | ZNF441 | ZNF442 | ZNF443 | ZNF444 | ZNF445 | ZNF446 | ZNF449 | ZNF45 | ZNF451 | ZNF454 | ZNF460 | ZNF461 | ZNF462 | ZNF467 | ZNF468 | ZNF469 | ZNF470 | ZNF471 | ZNF473 | ZNF473CR | ZNF479 | ZNF48 | ZNF480 | ZNF483 | ZNF484 | ZNF485 | ZNF486 | ZNF487 | ZNF488 | ZNF490 | ZNF491 | ZNF492 | ZNF493 | ZNF496 | ZNF497 | ZNF497-AS1 | ZNF500 | ZNF501 | ZNF502 | ZNF503 | ZNF503-AS1 | ZNF503-AS2 | ZNF506 | ZNF507 | ZNF510 | ZNF511 | ZNF512 | ZNF512B | ZNF513 | ZNF514 | ZNF516 | ZNF516-DT | ZNF517 | ZNF518A | ZNF518B | ZNF519 | ZNF519P3 | ZNF521 | ZNF524 | ZNF525 | ZNF526 | ZNF527 | ZNF528 | ZNF528-AS1 | ZNF529 | ZNF529-AS1 | ZNF530 | ZNF532 | ZNF534 | ZNF536 | ZNF540 | ZNF541 | ZNF542P | ZNF543 | ZNF544 | ZNF546 | ZNF547 | ZNF548 | ZNF549 | ZNF550 | ZNF551 | ZNF552